View Single Post
Old 10-02-2012, 02:35 PM   #3
caya
Senior Member
 
caya's Avatar
 
Join Date: Jan 2007
Location: Thornhill, Ontario Canada
Posts: 2,320
Re: 3000 person study-- her2+ early breast cancer divided into two groups by HR statu

Thanks for keeping on top of this Lani.

I'm sure those of us who are HR+ as well as HER2+ are grateful to the research being done on our small subsect of BC.

And I keep reminding myself that WE are the statistics... my onc. told me in Dec. 2006, just after my mastectomy and before I began chemo in January 2007, that I would be the future of HER2+ statistics as they had only been giving Herceptin to early stagers for about a year in Canada...

Going on six years now, no recurrence for me!!

all the best
caya
__________________
ER90%+/PR 50%+/HER 2+
1.7 cm and 1.0 cm.
Stage 1, grade 2, Node Negative (16 nodes tested)
MRM Dec.18/06
3 x FEC, 3 x Taxotere
Herceptin - every 3 weeks for a year, finished May 8/08

Tamoxifen - 2 1/2 years
Femara - Jan. 1, 2010 - July 18, 2012
BRCA1/BRCA2 Negative
Dignosed 10/16/06, age 48 , premenopausal
Mild lymphedema diagnosed June 2009 - breast surgeon and lymph. therapist think it's completely reversible - hope so.
Reclast infusion January 2012
Oopherectomy October 2013
15 Years NED!!
caya is offline   Reply With Quote